Integra LifeSciences selected for Healogics iSupply program

Integra LifeSciences Holdings announced it has been selected as a primary provider for cellular-based tissue products within Healogics new iSupply program. This program is exclusively available to Healogics’ hospital partners and is focused on ensuring hospitals and patients receive the best value from wound care products commonly used in Wound Care Centers and other sites of care. Under Healogics new iSupply program, Integra will be a lead provider for cellular-based tissue products, including AmnioExcel Amniotic Allograft Membrane, AMNIOMATRIX.”We are excited to be a primary provider of cellular-based tissue products for the iSupply program,” said Robert T. Davis, Jr., corporate vice president and president, Orthopedics and Tissue Technologies. “Integra’s products were selected through a rigorous analysis of published data and reviewed by Healogics’ value analysis committee of leading wound care clinicians. This partnership with Healogics reinforces Integra’s commitment to broader access to our advanced wound care products and improving outcomes for patients with chronic wounds.”
https://thefly.com/landingPageNews.php?id=2788209